Natural bioactive compound with anticancer potential

International Journal of Advances in Pharmaceutical Sciences

Volumn 1, Issue 1, 2010, Pages 32-41

  Patel, Bijal ^a   Das, Sattwik ^a   Prakash, Ravi ^a   Yasir, Mohammad ^a  

^a Malhotra College of Pharmacy   (India)

Author keywords

Anthraquinones; Cancer; Flavonides; Herbs

Indexed keywords

ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; BRUCEANTIN; BRYOSTATIN 1; CAMPTOTHECIN; CASPASE 3; CISPLATIN; COMBRETASTATIN A4; CYTARABINE; CYTOCHROME C; CYTOTOXIC AGENT; DEHYDRODIDEMNIN B; DOLASTATIN; DOLASTATIN 10; DOXORUBICIN; EMODIN; ETOPOSIDE; FLAVONOID; HERBACEOUS AGENT; IRINOTECAN; NATURAL PRODUCT; PLANT MEDICINAL PRODUCT; PODOPHYLLOTOXIN; PROTEIN P53; QUERCETIN; TENIPOSIDE; TRABECTEDIN; UNINDEXED DRUG; VINBLASTINE; VINDESINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

EID: 78951480810     PISSN: None     EISSN: 09761055     Source Type: Journal    
DOI: 10.5138/ijaps.2010.0976.1055.01003     Document Type: Article

References (55)

1. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z.Medicinal plant in therapy. Bull World Health Organ 1985, 63:965-981.
2. Cragg GM, Newman DJ, Snader KM. Natural Products in Drug Discovery and Development. J Nat Prod 1997, 60:52-60.
3. Balandrin MF, Kinghorn AD, Farnsworth NR: In Human Medicinal Agents from Plants. Edited by Kinghorn AD, Balandrin MF. North Carolina, USA: Oxford University Press USA; 1993:2-12. [American Chemical Society Symposium Series.]
4. Farnsworth NR. The role of ethnopharmacology in drug development. Ciba Found Symp 1990, 154:211.
5. Cragg GM, Newman DJ. Discovery and development of antineoplastic agents from natural sources. Cancer Invest 1999, 17:153-163. http://www.all4naturalhealth.com/herbs-for-cancer.html
6. Schwartsmann G. Marine organisms and other novel natural sources of new anticancer agents. Ann Oncol 2000, 11:235-243.
7. Schwartsmann G, Rocha AB, Berlinck R, Jimeno J. Marine organisms as a source of new anticancer drugs. Lancet Oncol 2001, 2:221-225.
8. Wang HK, Lee KH. Plant-derived anticancer agents and their analogs currently in clinical use or in clinical trials. Bot Bull Acad Sinica 1997; 38:225.
9. Lee KH. Biopharma Quart 1998; 3:12.
10. Barnett CJ, Cullinan GJ, Gerzon K, Hoying RC, Jones WE, Newlon WM, Poore GA, Robison RL, Sweeney MJ, Todd GC, Dyke RW, Nelson RL. Structure-activity relationships of dimeric Catharanthus alkaloids 1. Deacetyl vinblastine amide (vindesine) sulfate. J Med Chem 1978; 21:88.
11. Barnett CJ, Cullinan GJ, Gerzon K, Hoying RC, Jones WE, Newlon WM, Poore GA, Robison RL, Sweeney MJ, Todd GC, Dyke RW, Nelson RL. Structure-activity relationships of dimeric Catharanthus alkaloids 1. Deacetyl vinblastine amide (vindesine) sulfate. J Med Chem 1978; 21:88.
12. Cragg G, Suffness M. Metabolism of plant-derived anti-cancer agents. Pharmac Ther 1988; 37:425.
13. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Noval antitumor agents from higher plants.J Am Chem Soc 1966; 88:3808.
14. Wani MC, Nicholas AW, Wall ME. Plant antitumor agents 23. Synthesis and antileukemic activity of camptothecin analogs. J Med Chem 1986; 29:2358.
15. Johnson PK, McCabe FL, Faucette LF, Hertzberg RP, Kingsbury WD, Boehm JC, Caranfa MJ, Holden KG. Proc Amer Assoc Cancer Res 1989; 30:623.
16. Camptothecins: New Anticancer Agents. Potmesil M, Pinedo M, editors. Boca Raton, FL: CRC; 1995. p 113.
17. Fukuoka M, Negoro S, Niitani H, Taguchi T. Proc Amer Soc Clin Oncol 1990; 9:874.
18. Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular Roles of SN-38, a Metabolite of the Camptothecin Derivative CPT-11, in the Antitumor Effect of CPT-11.Cancer Res 1991;51:4187.
19. Camptothecins: New Anticancer Agents. Potmesil M, Pinedo M, editors. Boca Raton, FL: CRC; 1995. p 67.
20. Keller-Juslen C, Kuhn M, von Wartburg A, Stahelin H. Mitosis-inhibiting natural products. 24. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin. J Med Chem 1971; 14:936.
21. O'Dwyerm PJ, Alonso MT, Leyland-Jones B, Marsoni S. Teniposide: A review of 12 years of experience. Cancer Treat Rep 1984; 68:1455.
22. VePesid product information overview. Bristol Lab; 1983.
23. Etoposide (VP-16) current status and new developments. Issell BF, Muggia FM, Carter SK, editors. Orlando, FL: Academic; 1984.
24. Zhou XM, Lee KJH, Cheng J, Wu SS, Chen HX, Guo X, Cheng YC, Lee KH. Antitumor agents. 144. New gamma-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II. J Med Chem 1994; 37:287.
25. Bastow KF, Wang HK, Cheng YC, Lee KH. Antitumor agents--CLXXIII. Synthesis and evaluation of camptothecin-4 beta-amino-4'-O- demethyl epipodophyllotoxin conjugates as inhibitors of mammalian DNA topoisomerases and as cytotoxic agents. Bioorg Med Chem 1997; 5:1481.
26. Kashiwada Y, Nonaka G, Nishioka I, Lee KJ, Bori I, Fukushima Y, Bastow KF, Lee KH. Tannins as Potent Inhibitors of DNA Topoisomerase II In Vitro. J Pharm Sci 1993; 82:487.
27. Kashiwada Y, Nonaka G, Nishioka I, Chang JJ, Lee KH. Antitumor Agents, 129. Tannins and Related Compounds as Selective Cytotoxic Agents. J Natl Prod 1992; 55:1033.
28. Bastow KF, Bori ID, Fukushima Y, Kashiwada Y, Tanaka T, Nonaka G, Nishioka I, Lee KH. Inhibition of DNA Topoisomerases by Sanguiin H- 6, a Cytotoxic Dimeric Ellagitannin from Sanguisorba officinalis.Planta Med 1993; 59:240.
29. Chen CH, Yang LM, Lee TTY, Shen YC, Zhang DC, Pan DJ, McPhail AT, McPhail DR, Liu SY, Li DH, Cheng YC, Lee KH. Antitumor agents--CLI. Bis(helenalinyl)glutarate and bis(isoalantodiol- B)glutarate, potent inhibitors of human DNA topoisomerase II. Bioorg Med Chem 1994; 2:137.
30. Kashiwada Y, Bastow KF, Lee KH. Novel lignan derivatives as selective inhibitors of DNA topoisomerase II. Bioorg Med Chem Lett 1995; 5:905.
31. Lee KH, Imakura T, Sumida Y, Wu RY, Hall IH, Huang HC. Antitumor agents 33. Isolation and structural elucidation of bruceoside -A and -B, novel antileukemic quassinoid glycosides, and brucein -D and -E from Brucea javanica. J Org Chem 1979; 44:2180.
32. Fukamiya N, Okano M, Miyamoto M, Tagahara K, Lee KH. Antitumor Agents, 127. Bruceoside C, a New Cytotoxic Quassinoid Glucoside, and Related Compounds from Brucea javanica. J Natl Prod 1992; 55:468.
33. Onishi S, Fukamiya N, Okano M, Tagahara K, Lee KH. Bruceosides D, E, and F, three new cytotoxic quassinoid glucosides from Brucea javanica. J Natl Prod 1995; 58:1032.
34. Kupcahn SM, Britton RW, Lacadie JA, Ziegler MF, Sigel CW. The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica. J Org Chem 1975; 40:648.
35. Walle T, Otake Y, Brubaker JA, Walle UK, Halushka PV. 2001. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol 51: 143-146.
36. Mukhtar H, Das M, Khan WA, Bik DP. 1988. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethybenz(a)anthraxcene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-Nnitrosourea-induced skin tumorigenesis in mice. Cancer Res 48: 2361-2365.
37. Kuntz S, Wenzel U, Daniel H. 1999. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38: 133-142.
38. Knowles LM, Zigrossi DA, Tauber RA, Hightower C, Milner JA. 2000. Flavonoids suppress androgen-dependent human prostatic tumor proliferation. Nutr Cancer 38: 116-122.
39. Polkowski K, Mazurek AP. 2000. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm Drug Res 57: 135-155.
40. Valcic S, Timmermann BN, Alberts DS et al. 1996. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7: 461-468.
41. Scambia G, Raneletti FO, Panici PB et al. 1990. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs 1: 45-48.
42. Scambia G, Raneletti FO, Panici PB et al. 1992. Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis diamminedichloroplatinum (II). Gynecol Oncol 45: 13-19.
43. Scambia G, Ranelletti FO, Panici PB et al. 1994. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemotherapy Pharmacol 34: 459-464.
44. Versantvoort CHM, Schuurhuis GJ, Pinedo HM et al. 1993. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68: 939-946.
45. Zhang L, Chang CJ, Bacus SS, Hung MC. Suppressed transformation and induced differentiation of HER- 2/neu-overexpressing breast cancer cells by emodin. Cancer Res 1995; 55:3890.
46. Lee HZ, Hsu SL, Liu MC, Wu CH. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 2001; 431:287-295.
47. Yeh FT, Wu CH, Lee HZ. Int J Cancer 2003; 106:26-33.
48. Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21- dependent apoptotic pathway in human hepatoma cell lines. Life Sci 2002; 71:1879-1892.
49. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000; 60:2800-2804.
50. Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, Diaspro A, Carli M, Palumbo M, Palu G.Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 2003; 106:836-847.
51. Kuo PL, Hsu YL, Ng LT, Lin CC. Rhein inhibits the growth and induces the apoptosis of Hep G2 cells. Planta Med 2004; 70:12-16.
52. Acevedo-Duncan M, Russell C, Patel S, Patel R. Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells. Int Immunopharmacol 2004; 4:1775-1784.
53. Kamei H, Koide T, Kojima T, HashimotoY, Hasegawa M. Inhibition of cell growth in culture by quinones. Cancer Biother Radiopharm 1998; 13:185.
54. Sanjeev Banerjee, Zhiwei Wang, Mussop Mohammad, Fazlul H. Sarkar, and Ramzi M. Mohammad. Efficacy of Selected Natural Products as Therapeutic Agents against Cancer. J. Nat. Prod. 2008, 71, 492-496
55. Chen HC, Hsieh WT, Chang WC, Chung JG. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 2004; 42:1251-1257.